Testicular Cancer - Results from #480

REVIEW UroToday

An Updated Systematic Review of Quantitative Studies Assessing Anxiety, Depression, Fear of Cancer Recurrence or Psychological Distress in Testicular Cancer Survivors. May 21, 2021

Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment. May 20, 2021

Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer. May 17, 2021

Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing. May 17, 2021

Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors. May 12, 2021

Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study. May 10, 2021

[Active surveillance for testicular tumors: adherence and safety.] May 7, 2021

Dataset of testicular germ cell tumors (TGCT) risk associated with serum polychlorinated biphenyl (PCB) by age at diagnosis and histologic types. May 6, 2021

Quality of life, anxiety and depression patient-reported outcome measures in testicular cancer: A systematic review. May 5, 2021

Psychological Needs Satisfaction, Self-Rated Health and the Mediating Role of Exercise Among Testicular Cancer Survivors. May 4, 2021

Role of contrast-enhanced ultrasound with Sonazoid in management of small testicular Leydig cell tumours: A case report with literature review. April 30, 2021

Immunohistochemical Detection of Cancer-Testis Antigen PRAME. April 27, 2021

Testicular cancer follow-up costs in Germany from 2000 to 2015. April 26, 2021

Testicular tumor markers in the spermatic vein - correlation to pathology, stage and outcome. April 23, 2021

The Association Between Testicular Self-Examination and Stages of Testicular Cancer Diagnosis: A Cross-Sectional Analysis. April 22, 2021

A 25-year review of advances in testicular cancer: Perspectives on evaluation, treatment, and future directions/challenges. April 20, 2021

Identification and validation of a five apoptosis-related genes signature for prediction of disease-free survival for testicular germ cell tumors. April 19, 2021

Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study. April 16, 2021

Pre-Implementation Assessment of the Acceptability of Using Circulating microRNAs for Follow-Up of Malignant Germ-Cell Tumors. April 15, 2021

Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples. April 12, 2021

Page 25 of 94